Recruiting

Vaccine Responses in Patients With B Cell Malignancies

Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Code:

NCT05170399

Conditions

Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Fluzone

Shingrix

Flucelvax

Afluria

PREVNAR 13

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information